Stocks
Actuate Therapeutics, Inc. Common stockACTU
NASDAQHealthcareBiotechnology$0.48
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing therapies for aggressive cancers, with a lead candidate targeting hard-to-treat solid tumors. Its pipeline and early-stage trial data make it a name to watch for investors focused on oncology innovation.
52W Range: $0.41-$7.90
Congressional Interest in Actuate Therapeutics, Inc. Common stock (ACTU)
No congressional trades have been disclosed for Actuate Therapeutics, Inc. Common stock (ACTU) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ACTU?
No congressional trades found for this stock.